Review discusses dietary organosulfur compounds' impact on viral infection and inflammation, indicating their potential against multiple diseases.
Phytonutrients are widely recognized for their protective health benefits in humans. Mounting studies suggest that dietary organosulfur compounds play a significant role in preventing various pathological conditions. Organosulfur compounds, such as diallyl disulfide, diallyl trisulfide, alliin, allicin, S ‐allyl cysteine, and sulforaphane, possess broad pharmacological activities, making them versatile therapeutic agents. Their antiviral, antibacterial, anti‐inflammatory, anticancer, and antioxidant properties, along with their effectiveness in managing cardiovascular diseases (CVDs), obesity, and diabetes, highlight their potential as single‐drug solutions for multiple health issues simultaneously. Plants belonging to Allium genus and Brassicaceae family are the most predominant sources of these compounds. This review aims to summarize the different natural sources and bioavailability of various organosulfur compounds as well as discuss the therapeutic potential of various organosulfur compounds in response to viral/bacterial infection, inflammation, cancer, oxidative stress, CVDs, obesity, and diabetes with special emphasis on SARS‐CoV‐2. This review also includes the effective doses as well as the mode of action underlying the therapeutic potential of specific organosulfur compound against respective pathophysiology. The outcome of this review will open new avenue for further investigation of organosulfur compounds against different pathophysiology and that will be helpful for the development of innovative therapeutics with promising health benefits.
No takes yet. Share an insight, caveat, or question.
Barman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: